Showing 1 - 20 results of 32 for search 'Feng-Ming (Spring) Kong', čas poizvedbe: 0.09s
Refine Results
-
1
-
2
-
3
-
4
-
5
Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients od Hao Yu, Hao Yu, Ka-On Lam, Ka-On Lam, Huanmei Wu, Michael Green, Michael Green, Weili Wang, Jian-Yue Jin, Chen Hu, Shruti Jolly, Yang Wang, Feng-Ming Spring Kong, Feng-Ming Spring Kong, Feng-Ming Spring Kong
Izdano 2021-02-01
Article -
6
Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy od Yinnan Meng, Yinnan Meng, Wei Luo, Wei Wang, Wei Wang, Chao Zhou, Chao Zhou, Suna Zhou, Suna Zhou, Xingni Tang, Xingni Tang, Liqiao Hou, Liqiao Hou, Feng-Ming Spring Kong, Feng-Ming Spring Kong, Feng-Ming Spring Kong, Haihua Yang, Haihua Yang
Izdano 2020-10-01
Article -
7
Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach od Hao Yu, Fang Chen, Fang Chen, Ka-On Lam, Ka-On Lam, Li Yang, Yang Wang, Jian-Yue Jin, Aya EI Helali, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong
Izdano 2022-06-01
Article -
8
Derivation of a comprehensive semi-empirical proton RBE model from published experimental cell survival data collected in the PIDE database od Jian-Yue Jin, Jian-Yue Jin, Jiankui Yuan, Xiaohang Qin, Yinghui Li, Huagang Yan, Nancy L. Oleinick, Min Yao, Quintin Pan, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong, Mitchell Machtay
Izdano 2024-11-01
Article -
9
Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer od Hong Zhang, Weili Wang, Wenhu Pi, Nan Bi, Colleen DesRosiers, Fengchong Kong, Monica Cheng, Li Yang, Tim Lautenschlaeger, Shruti Jolly, Jianyue Jin, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong
Izdano 2021-07-01
Article -
10
Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma od Ye Wang, Ye Wang, Yingqiu Song, Runze Wang, Yu Wu, Yu Wu, Mo Li, Ke Xu, Rong He, Zheng Wang, Qingqing Li, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong, Tianlu Wang, Tianlu Wang
Izdano 2024-04-01
Article -
11
Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis od Haiyan Zeng, Danyang Zheng, Danyang Zheng, Willem J. A. Witlox, Antonin Levy, Antonin Levy, Alberto Traverso, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong, Ruud Houben, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks
Izdano 2022-06-01
Article -
12
A Transfer Learning Framework for Deep Learning-Based CT-to-Perfusion Mapping on Lung Cancer Patients od Ge Ren, Bing Li, Bing Li, Sai-kit Lam, Haonan Xiao, Yu-Hua Huang, Andy Lai-yin Cheung, Yufei Lu, Ronghu Mao, Hong Ge, Feng-Ming (Spring) Kong, Feng-Ming (Spring) Kong, Wai-yin Ho, Jing Cai
Izdano 2022-07-01
Article -
13
Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies. od Jing Zhao, Yingfeng Xia, Joseph Kaminski, Zhonglin Hao, Frank Mott, Jeff Campbell, Ramses Sadek, Feng-Ming Spring Kong
Izdano 2016-01-01
Article -
14
Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis od Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Izdano 2021-12-01
Article -
15
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer od Fang Chen, Fang Chen, Jian-Yue Jin, Timothy S.K. Hui, Haiman Jing, Hong Zhang, Yaqing Nong, Ying Han, Weili Wang, Lingyu Ma, Fan Yi, Qingqing Chen, Yongsheng Zhang, Pingfu Fu, Li Yang, Zhiyuan Xu, Feng-Ming Spring Kong, Feng-Ming Spring Kong
Izdano 2022-04-01
Article -
16
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation od Brittany Z. Dashevsky, Chenpeng Zhang, Li Yan, Cindy Yuan, Lingyun Xiong, Yongmei Liu, Haiyan Liu, Feng-Ming Spring Kong, Yonglin Pu
Izdano 2017-12-01
Article -
17
-
18
-
19
-
20